UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
1,519,100
1,627,800
1,725,300
1,598,800
1,465,761
Cost of Revenue
120,700
198,700
105,700
72,700
69,036
Gross Profit
1,398,400
1,429,100
1,619,600
1,526,100
1,396,725
Operating Expenses
Research Development
1,207,800
357,900
264,600
147,600
245,098
Selling General and Administrative
310,200
265,800
330,100
316,800
452,612
Total Operating Expenses
1,518,000
623,700
594,700
464,400
697,710
Operating Income or Loss
-119,600
805,400
1,024,900
1,061,700
699,015
Interest Expense
38,500
13,900
9,000
3,900
4,735
Total Other Income/Expenses Net
-24,700
-61,200
-246,400
2,400
350,157
Income Before Tax
-141,400
758,900
769,500
1,060,200
1,044,437
Income Tax Expense
-49,600
169,700
351,600
346,500
392,798
Income from Continuing Operations
-91,800
589,200
417,900
713,700
651,639
Net Income
-91,800
589,200
417,900
713,700
651,639
Net Income available to common shareholders
-91,800
589,200
417,900
713,700
651,639
Reported EPS
Basic
-
13.54
9.50
16.29
14.17
Diluted
-
13.39
9.31
15.25
12.72
Weighted average shares outstanding
Basic
-
43,500
44,000
43,800
46,000
Diluted
-
44,000
44,900
46,800
51,221
EBITDA
-
772,800
778,500
1,095,700
1,082,093